Citigroup
ANRO icon

Citigroup’s Alto Neuroscience ANRO Stock Holding History

Citigroup’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
20,745
+11,315
+120% +$262K ﹤0.01% 3851
2026
Q1 		$212K Sell
9,430
-3,136
-25% -$58.1K ﹤0.01% 3982
2025
Q4 		$224K Buy
+12,566
New +$158K ﹤0.01% 3949
2025
Q3 		– Sell
-2,303
Closed -$5.07K – 6356
2025
Q2 		$5.07K Sell
2,303
-12,841
-85% -$30.6K ﹤0.01% 5278
2025
Q1 		$32.7K Sell
15,144
-1,705
-10% -$6.1K ﹤0.01% 4991
2024
Q4 		$71.3K Buy
16,849
+1,383
+9% +$8.63K ﹤0.01% 4972
2024
Q3 		$177K Buy
15,466
+13,513
+692% +$165K ﹤0.01% 4422
2024
Q2 		$20.9K Sell
1,953
-31,889
-94% -$415K ﹤0.01% 4988
2024
Q1 		$519K Buy
+33,842
New +$530K ﹤0.01% 3546

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Citigroup's ANRO Position: Q2 2026 in Review

Citigroup increased its Alto Neuroscience (ANRO) stake by 120% in Q2 2026, buying an estimated $262K and bringing the position to 20,745 shares worth $547K. The position accounts for ﹤0.01% of the portfolio, ranked #3851.

Citigroup first reported a position in ANRO in Q1 2024 and has held it in 9 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Citigroup held 20,745 shares of Alto Neuroscience worth $547K as of Q2 2026.
  • Citigroup bought 11,315 Alto Neuroscience shares in Q2 2026, an estimated $262K.
  • Alto Neuroscience made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3851 holding.
  • Citigroup first reported a position in Alto Neuroscience in Q1 2024 and has held it in 9 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.